Eric A Wold

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 11

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

International journal of molecular sciences

Molecules (Basel, Switzerland)

University of Texas Medical Branch (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Texas Medical Branch

United States

PHD

University of Houston

United States

BSC

Publications

Zhi-Qing Liu, Yi Li, Haiying Chen, Hsien-Tsung Lai, Pingyuan Wang, Shwu-Yuan Wu, Eric A Wold, Paul G Leonard, Sarah Joseph, Haitao Hu, Cheng-Ming Chiang, Allan R Brasier, Bing Tian, Jia Zhou
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. Journal of medicinal chemistry 65 (3) (2022)
Zhi-Qing Liu, Pingyuan Wang, Eric A Wold, Qiaoling Song, Chenyang Zhao, Chang-Yun Wang, Jia Zhou
Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer. Journal of medicinal chemistry 64 (8) (2021)
Jimin Xu, Judith Berastegui-Cabrera, Marta Carretero-Ledesma, Haiying Chen, Yu Xue, Eric A Wold, Jerónimo Pachón, Jia Zhou, Javier Sánchez-Céspedes
Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome. International journal of molecular sciences 22 (4) (2021)
Na Ye, Wangzhi Qin, Sheng Tian, Qingfeng Xu, Eric A Wold, Jia Zhou, Xue-Chu Zhen
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. Journal of medicinal chemistry 63 (24) (2020)
Zhi-Qing Liu, Haiying Chen, Pingyuan Wang, Yi Li, Eric A Wold, Paul G Leonard, Sarah Joseph, Allan R Brasier, Bing Tian, Jia Zhou
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation. Journal of medicinal chemistry 63 (10) (2020)
Eric A Wold, Erik J Garcia, Christopher T Wild, Joanna M Miszkiel, Claudia A Soto, Jianping Chen, Konrad Pazdrak, Robert G Fox, Noelle C Anastasio, Katherine A Cunningham, Jia Zhou
Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties. Journal of medicinal chemistry 63 (14) (2020)
Jimin Xu, Eric A Wold, Ye Ding, Qiang Shen, Jia Zhou
Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection. Molecules (Basel, Switzerland) 23 (2) (2018)
Ye Ding, Dengfeng Li, Chunyong Ding, Pingyuan Wang, Zhiqing Liu, Eric A Wold, Na Ye, Haiying Chen, Mark A White, Qiang Shen, Jia Zhou
Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads. Journal of medicinal chemistry 61 (7) (2018)
Na Ye, Bang Li, Qi Mao, Eric A Wold, Sheng Tian, John A Allen, Jia Zhou
Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target. ACS chemical neuroscience 10 (1) (2018)
Eric A Wold, Jianping Chen, Katherine A Cunningham, Jia Zhou
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. Journal of medicinal chemistry 62 (1) (2018)
Christopher T Wild, Joanna M Miszkiel, Eric A Wold, Claudia A Soto, Chunyong Ding, Rachel M Hartley, Mark A White, Noelle C Anastasio, Katherine A Cunningham, Jia Zhou
Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor. Journal of medicinal chemistry 62 (1) (2018)

Eric A Wold.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eric A Wold